IP Library › Granted Patent US 11,925,462
Granted Patent B2
US 11,925,462 · App. 15/414,177 · Granted Mar 12, 2024

System and method for analyzing glucose monitoring data indicative of a glucose level, and a computer program product

Inventors: Matthias Koehler (Laudenbach, DE); Timm Wiedemann (Mannheim, DE)
Assignee: Roche Diabetes Care, Inc.
A61B5/14532A61B5/7275A61B5/742G16H10/60G16H40/63
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,925,462
App. No.
15/414,177
Granted
Mar 12, 2024
Kind
B2
Abstract

A system for analyzing glucose monitoring data indicative of a glucose level in a bodily fluid. The system includes an input device, a data processing device, an output device, a display device, and machine readable instructions that are executed by the data processing device, wherein the machine readable instructions cause the data processing device to receive glucose monitoring data via the input device, the glucose monitoring data indicating a glucose level in a bodily fluid sampled for a person at a plurality of sample times over a measurement time period in a glucose level measurement, and comprising a plurality of glucose profiles, each of the glucose profiles comprising a plurality of glucose values assigned to one of the plurality of sample times. Furthermore, a method for analyzing glucose monitoring data indicative of a glucose level in a system is provided.

Claims (77)

1. A method for analyzing glucose monitoring data, comprising:

using a system which includes:

a data processing device; and

a display device, to perform the steps of:

receiving glucose monitoring data, the glucose monitoring data:

indicating a glucose level sampled from a bodily fluid of a person at a plurality of sample times over a measurement time period in a glucose level measurement; and

comprising a plurality of glucose profiles, each of the glucose profiles comprising a plurality of glucose values each assigned to one of the plurality of sample times;

for the plurality of glucose profiles, determining a minimum glucose value and a maximum glucose value for each of a selected group of sample times or each of the plurality of sample times, wherein the glucose monitoring data includes minimum glucose values higher than a pre-determined low glucose value and maximum glucose values smaller than a pre-determined high glucose value;

providing first display signals representing the minimum glucose value aid the maximum glucose value for each of the selected group of sample times or each of the plurality of sample times in the form of a curve;

outputting the first display signals to the display device;

displaying a first graphical representation according to the first display signals on the display device; and

substituting, for one or more samples times in the curve representing the minimum glucose value and the curve representing the maximum glucose value for each of the selected group of sample times or each of the plurality of samples times:

the minimum glucose value by the pre-determined low glucose value when the minimum glucose value is determined higher than the pre-determined low glucose value; and

the maximum glucose value by the pre-determined high glucose value when the maximum glucose value is determined smaller than the pre-determined high glucose value,

wherein the first graphical representation includes:

i) a minimum line which includes the curve representing the minimum glucose value for each of the selected group of sample times or each of the plurality of sample times and the pre-determined low glucose value; and

ii) a maximum line which includes the curve representing the maximum glucose value for each of the selected group of sample times or each of the plurality of sample times and the pre-determined high glucose value; and

making a decision to increase a basal rate dosage of insulin to the person based upon a review of the first graphical representation by examining the minimum line and determining that there are no outliers below a hypoglycemic boundary, and administering the increased dosage to the person.

2. The method according to claim 1 , wherein the first display signals represent a continuous curve for at least one of the minimum glucose value and the maximum glucose value for each of the selected group of sample times or each of the plurality of sample times.

3. The method according to claim 2 further comprising:

determining an ambulatory glucose profile for the plurality of glucose values of the plurality of glucose profiles; and

providing the first display signals further representing the ambulatory glucose profile.

4. The method according to claim 2 further comprising:

providing second display signals, the second display signals representing the plurality of glucose profiles;

outputting the second display signals to the display device; and

displaying a second graphical representation according to the second display signals on the display device.

5. The method according to claim 1 wherein the first display signals represent a discontinuous curve provided with separated curve segments for at least one of the minimum glucose value and the maximum glucose value for each of the selected group of sample times or each of the plurality of sample times.

6. The method according to claim 5 further comprising:

determining an ambulatory glucose profile for the plurality of glucose values of the plurality of glucose profiles; and

providing the first display signals further representing the ambulatory glucose profile.

7. The method according to claim 1 further comprising:

determining an ambulatory glucose profile for the plurality of glucose values of the plurality of glucose profiles; and

providing the first display signals further representing the ambulatory glucose profile.

8. The method according to claim 1 :

providing second display signals, the second display signals representing the plurality of glucose profiles;

outputting the second display signals to the display device; and

displaying a second graphical representation according to the second display signals on the display device.

9. The method according to claim 8 further comprising:

providing third display signals, the third display signals representing a glucose threshold value;

outputting the third display signals to the display device; and

displaying a third graphical representation according to the third display signals on the display device.

10. The method according to claim 9 further comprising:

providing fourth display signals, the fourth display signals representing a target range for the glucose levels of the glucose monitoring data;

outputting the fourth display signals to the display device; and

displaying a fourth graphical representation according to the fourth display signals on the display device.

11. The method according to claim 1 further comprising:

providing second display signals, the second display signals representing a glucose threshold value;

outputting the second display signals to the display device; and

displaying a second graphical representation according to the second display signals on the display device.

12. The method according to claim 1 further comprising:

providing second display signals, the second display signals representing a target range for the glucose levels of the glucose monitoring data;

outputting the second display signals to the display device; and

displaying a second graphical representation according to the fourth display signals on the display device.

13. The method according to claim 1 wherein the glucose monitoring data analyzed by the system and received by the data processing device is continuous glucose monitoring data, the continuous glucose monitoring data indicating a glucose level sampled from the bodily fluid of the person at the plurality of sample times over a measurement time period in a continuous glucose level measurement.

14. The method according to claim 1 wherein the step of administering the dosage to the person is performed with a medication delivery device communicatively coupled with the data processing device.

15. A method for analyzing glucose monitoring data, comprising:

using a system which includes:

a data processing device; and

a display device, to perform the steps of:

receiving glucose monitoring data, the glucose monitoring data:

indicating a glucose level sampled from a bodily fluid of a person at a plurality of sample times over a measurement time period in a glucose level measurement; and

comprising a plurality of glucose profiles, each of the glucose profiles comprising a plurality of glucose values each assigned to one of the plurality of sample times;

for the plurality of glucose profiles, determining a minimum glucose value and a maximum glucose value for each of a selected group of sample times or each of the plurality of sample times, wherein the glucose monitoring data includes minimum glucose values higher than a pre-determined low glucose value and maximum glucose values smaller than a pre-determined high glucose value;

providing first display signals representing the minimum glucose value aid the maximum glucose value for each of the selected group of sample times or each of the plurality of sample times in the form of a curve;

outputting the first display signals to the display device;

displaying a first graphical representation according to the first display signals;

determining an ambulatory glucose profile for the plurality of glucose values of the plurality of glucose profiles, wherein the first display signals further represent the ambulatory glucose profile and the ambulatory glucose profile represented by the first display signals consists of percentile curves for glucose values; and

substituting, for one or more sample times in the curve representing the minimum glucose value and the curve representing the maximum glucose value for each of the selected group of sample times or each of the plurality of sample times:

the minimum glucose value by the pre-determined low glucose value when the minimum glucose value is determined higher than the pre-determined low glucose value; and

the maximum glucose value by the pre-determined high glucose value when the maximum glucose value is determined smaller than the pre-determined high glucose value,

wherein the first graphical representation includes:

i) a minimum line which includes the curve representing the minimum glucose value for each of the selected group of sample times or each of the plurality of sample times and the pre-determined low glucose value; and

ii) a maximum line which includes the curve representing the maximum glucose value for each of the selected group of sample times or each of the plurality of sample times and the pre-determined high glucose value; and

making a decision to increase a basal rate dosage of insulin to the person based upon a review of the first graphical representation by examining the minimum line and determining that there are no outliers below a hypoglycemic boundary, and administering the increased dosage to the person.

16. The method according to claim 15 wherein the step of administering the dosage to the person is performed with a medication delivery device communicatively coupled with the data processing device.

17. The method according to claim 15 , wherein the first graphical representation of glucose monitoring data on the display device is limited to the minimum line, the maximum line, and the ambulatory glucose profile; and

wherein the first graphical representation is the only graphical representation of glucose monitoring data displayed by the display device when displaying the first graphical representation of glucose monitoring data on the display device.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 27, 2017
From: KOEHLER, MATTHIAS; WIEDEMANN, TIMM
To: ROCHE DIABETES CARE GMBH
Reel/Frame 041536/0721 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 27, 2017
From: ROCHE DIABETES CARE GMBH
To: ROCHE DIABETES CARE, INC.
Reel/Frame 041536/0972 →
Priority Claims (1)
EP 16153964 · Feb 2, 2016 · regional
Continuity (1)
Related Publication 20170215774A1 · Aug 3, 2017